跳至主要内容
临床试验/CTRI/2021/07/034819
CTRI/2021/07/034819招募中未知

A Prospective, Multicentric, Non-Interventional Data Collection Registry to report the safety & feasibility of 3D OCT-Guided Distal Left Main Bifurcation Percutaneous Coronary Intervention with Everolimus-Eluting Stents in South Asian setting

Meditrina Hospitals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients of either gender, aged between 20 and 80 years with a diagnosis of stable ischemic heart disease (SIHD) or acute coronary syndrome (ACS)
  • 2. PCI with single or multiple EES for the treatment of lesion located at left main coronary artery (LMCA) bifurcation and defined as a diameter stenosis >= 50% by visual estimation
  • 3. Lesions suitable to be treated with OCT guided Distal LM PCI
  • 4. Patients willing to sign the informed consent form

排除标准

  • 1. Patients unwilling to sign the informed consent
  • 2. ST-elevation myocardial infarction (STEMI)
  • 3. Hemodynamic instability (cardiogenic shock)
  • 4. Patients who have a life expectancy of less than 12 months
  • 5. Contraindication for dual antiplatelet therapy (DAPT)

研究者

发起方
Meditrina Hospitals Pvt Ltd

相似试验